Correction: Characteristics and treatment outcome in a prospective cohort of 639 advanced high-grade digestive neuroendocrine neoplasms (NET G3 and NEC). The NORDIC NEC 2 study.

Sorbye, HalfdanHalfdanSorbyeHjortland, Geir OlavGeir OlavHjortlandVestermark, Lene WeberLene WeberVestermarkLadekarl, MortenMortenLadekarlSvensson, JohannaJohannaSvenssonSundlöv, AnnaAnnaSundlövJanson, Eva TiensuuEva TiensuuJansonGarresori, HerishHerishGarresoriHofsli, EvaEvaHofsliKersten, ChristianChristianKerstenElvebakken, HegeHegeElvebakkenPfeiffer, PerPerPfeifferMorken, SirenSirenMorkenAssmus, JorgJorgAssmusLothe, Inger Marie BowitzInger Marie BowitzLotheTabaksblat, ElizavetaElizavetaTabaksblatKnigge, UlrichUlrichKniggeCouvelard, AnneAnneCouvelardPerren, AurelAurelPerren0000-0002-6819-6092Langer, Seppo WSeppo WLanger2025-07-162025-07-162025-07-14https://boris-portal.unibe.ch/handle/20.500.12422/213341en600 - Technology::610 - Medicine & healthCorrection: Characteristics and treatment outcome in a prospective cohort of 639 advanced high-grade digestive neuroendocrine neoplasms (NET G3 and NEC). The NORDIC NEC 2 study.article10.48620/895694065985910.1038/s41416-025-03095-1